TABLE 1

Primers used in this study for promoter cloning, mutagenesis, real-time PCR, EMSAs, and ChIP assays

PCR primers are numbered relative to the adenine base of the initiator codon (ATG), which is assigned as +1. Incorporated restriction sites of both MulI (ACGCGT) and KpnI (GGTACC) are underlined. Oligonucleotides are the same for both mutagenesis and EMSAs. Mutated sequences are highlighted in bold.


Primer

Nucleotide Sequence (5′ to 3′)
PCR and cloning
    2B15-54For AGCCATGGTACCGAGAAATGACAGAAAG
    2B15-101For AGCCATGGTACCTAGCAGTTATATTTTAAC
    2B15-154For AGCCATGGTACCTCCTTGGCATGCACCTATTC
    2B15-202For AGCCATGGTACCCACCAAACACACTAAAA
    2B15-253For AGCCATGGTACCCTAGGTCATAAAAATTA
    2B15-310For AGCCATGGTACCGCCACTGTTCTTAACAGT
    2B15-361For AGCCATGGTACCTACTTCTTCTCTCTATGTC
    2B15-412For AGCCATGGTACCAAGACATTACTTGCACCACGA
    2B15-458For AGCCATGGTACCTTGGTGAGTCATATGGC
    2B15-556For AGCCATGGTACCGAGGCTATTGTATAGAATC
    2B15-595For AGCCATGGTACCTAGGGTAGGATGGATG
    2B15-705For AGCCATGGTACCAATCTAGTCCTGCATCC
    2B15-747For AGCCATGGTACCTTCACAATGCAAGCCTCTG
    2B15-2716For AAATCTGGGTACCACATAATGCCTGCACT
    2B15-3Rev AGAACGCGTGGTCTTATGCAATGCTTCTT
Site-directed mutagenesis/EMSA
    5′AP-1wt GTACACACTAATTGGTGAGTCATATGGTATATG
    5′AP-1m GTACACACTAATTGGCAGAGCATATGGTATATG
    3′AP-1wta* GGTATATGAATTATGTGTCAACAAAGTTTTAGAAGAC
    3′AP-1ma* GGTATATGAATTACAGAGCAACAAAGTTTTAGAAGAC
    3′AP-1wtb TATGAATTATGTGTCAACAAAGTTT
    3′AP-1mb TATGAATTACAGAGCAACAAAGTTT
    3′EREhwt AAATAAATATGAGGTCATCAATCTTTTGTTG
    3′EREhm AAATAAATATGAAAAAATCAATCTTTTGTTG
    5′EREhwt CTTACATATTCTAGGTCATAAAAATTATTG
    5′EREhm CTTACATATTCTATTTTTTAAAAATTATTG
    EREfwt CTCTCTATGTCAAGGGCACCGAACAGGC
    EREfm CTTCTTCTCTCTAAAAAGAGGGCACCGAAC
    X. laevis VitellogeninA2 vitERE AAAGTCAGGTCACAGTGACCTGATCAAAG
Quantitative real-time PCR
    c-Fos-For TGATGACCTGGGCTTCCCAG
    c-Fos-Rev CAAAGGGCTCGGTCTTCAGC
    c-Jun-For CTTCAACCCAGGCGCGCTGAGCA
    c-Jun-Rev GTCTGAGGCTCCTCCTTCAGGGCCT
    ERα-For TTCGGCTCCAACGGCCTGGGGGGTTT
    ERα-Rev GGTACTGGCCAATCTTTCTCTGCCACCCT
    Fra-2-For TAGATATGCCTGGCTCAGGCAGTGCA
    Fra-2-Rev TCTTGATCACGCCAGGTCTTGGGA
    18S rRNA-For CGATGCTCTTAGCTGAGTGT
    18S rRNA-Rev GGTCCAAGAATTTCACCTCT
    1A3-For ATGGCAATGTTGAACAATATG
    1A3-Rev GGTCTGAATTGGTTGTTAGTAATC
    1A7-For TGGCTCGTGCAGGGTGGACTG
    1A7-Rev TTCGCAATGGTGCCGTCCAGC
    1A8-For CTGCTGACCTGTGGCTTTGCT
    1A8-Rev CCATTGAGCATCGGCGAAAT
    2B28-For TCTTTTTGATCCCAATGACGCATT
    β-Actin-For CTGGCGGCACCACCATGTACCCT
    β-Actin-Rev GGAGGGGCCGACTCGTCATACT
ChIP assay
    2B15-ChipF1 TGCCGTTTGAGTTGTATAATTACTTCTTC
    2B15-ChipR1 GAATAGGTGCATGCCAAGGAGACC
    2B15-ChipF2 GGGGGGTTAGAGGCTATTGTATAGA
    2B15-ChipR2 GAATATGTAAGTAACCTGTCTTATGT
    2B15-ChipR3 TTAATATCGTGGTGCAAGTAATGTCTTC
    2B15-ChipF3 GAGTGGGGGGTTAGAGGCTATTGTATAG
    HCG3-ChipF ATGGTGGACTACTACGAGGT
    HCG3-ChipR CACCTGCTTGAATCTCCTCT
    TFF1/pS2-For GGCCATCTCTCACTATGAATCACTTCTGC
    TFF1/ps2-Rev
GGCAGGCTCTGTTTGCTTAAAGAGCG
  • F, forward; For, forward; R, reverse; Rev, reverse; EREhwt, ERE wild-type half-site; EREhm, ERE mutant half-site; EREfwt, imperfect ERE full site; EREfm, ERE mutant full site.

  • * Used for the proximal AP-1 site in mutagenesis.

  • Used for the proximal AP-1 site in EMSAs.